Multiple myeloma-associated amyloidosis and giant cell arteritis

Arthritis and Rheumatism

Volumn 41, Issue 7, 1998, Pages 1312-1317

  Estrada, Adahli ^a   Stenzel, Timothy T ^a   Burchette, James L ^a   Allen, Nancy B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMYLOIDOSIS; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIPLE MYELOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; SYMPTOMATOLOGY; VASCULITIS;

AGED; AMYLOIDOSIS; B-LYMPHOCYTES; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MACROPHAGES; MULTIPLE MYELOMA; T-LYMPHOCYTES; TEMPORAL ARTERITIS;

EID: 0031809548     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199807)41:7<1312::AID-ART23>3.0.CO;2-T     Document Type: Article

References (24)

1. Salvarani C, Gabriel SE, Gertz MA, Bjornsson J, Li C-Y, Hunder GG. Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 1994;37:1621-6.
2. Gertz MA, Kyle RA, Griffing WL, Hunder GG. Jaw claudication in primary systemic amyloidosis. Medicine (Baltimore) 1986;65: 173-9.
3. Rao JK, Allen NB. Primary systemic amyloidosis masquerading as giant cell arteritis: case report and review of the literature. Arthritis Rheum 1993;36:422-5.
4. Lukitsch O, Gebhardt KP, Kovary PM. Follicular hyperkeratosis and cryocrystalglobulinemia syndrome: occurrence in a patient with multiple myeloma. Arch Dermatol 1985;121:795-8.
5. Yiannias JA, el-Azhary RA, Gibson LE. Erythema elevatum diutinum: a clinical and histopathologic study of 13 patients. J Am Acad Dermatol 1992;26:38-44.
6. Nelson EA, Gibson B. The management of leg ulcers in a patient with ulcerative colitis. J Wound Care 1995;4:391-3.
7. Gelber M. Polymyalgia rheumatica as the presenting symptom of multiple myeloma. Harefuah 1995;128:544-5.
8. Zawadzki ZA, Benedek TG. Rheumatoid arthritis, dysproteinemic arthropathy, and paraproteinemia. Arthritis Rheum 1969;12:555-68.
9. Kyle RA. Current concepts on monoclonal gammopathies. Aust N Z J Med 1992;22:291-302.
10. Calamia KT, Hunder GG. Clinical manifestations of giant cell (temporal) arteritis. Clin Rheum Dis 1980;6:389-403.
11. Heptinstall RH, Porter KA, Barkley H. Giant-cell (temporal) arteritis. J Pathol 1954;67:507-19.
12. Meretoja J, Tarkkanen A. Amyloid deposits of internal elastic lamina in temporal arteritis. Ophthalmologica 1975;170:337-44.
13. Muckle TJ. Giant cell inflammation compared with amyloidosis of the internal elastic lamina in temporal arteries. Arthritis Rheum 1988;31:1186-9.
14. Reid AH, Maloney AFJ. Giant cell arteritis and arteriolitis associated with amyloid angiopathy in an elderly mongol. Acta Neuropathol (Berl) 1974;27:131-7.
15. Murphy MN, Sima AA. Cerebral amyloid angiopathy associated with giant cell arteritis: a case report. Stroke 1984;16:514-7.
16. Shintaku M, Osawa K, Toki J, Maeda R, Nishiyama T. A case of granulomatous angiitis of the central nervous system associated with amyloid angiopathy. Acta Neuropathol (Berl) 1986;70:340-2.
17. Mandybur TI. Cerebral amyloid angiopathy: possible relationship to rheumatoid vasculitis. Neurology 1979;29:1336-40.
18. Sundy JS, Haynes BF. Pathogenic mechanisms of vessel damage in vasculitis syndromes. Rheum Dis Clin North Am 1995;21:861-81.
19. Fauci AS, Haynes BF, Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 1978;89:660-76.
20. Rasmussen N, Petersen J. Cellular immune responses and pathogenesis in c-ANCA positive vasculitides. J Autoimmun 1993;6: 227-36.
21. Cathcart ES. Infiltrative disorders associated with rheumatic diseases. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, editors. Textbook of rheumatology. 4th ed. Philadelphia: WB Saunders; 1993. p. 1413-43.
22. Merlini G. Treatment of primary amyloidosis. Semin Hematol 1995;32:60-79.
23. Skinner M, Anderson JJ, Simms R, Falk R, Wang M, Libbey CA, et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 1996;100:290-8.
24. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 1997;36:1202-7.